Nitrofurantoin BE study [Regulatives / Guidelines]

posted by Dr_Dan  – Germany, 2015-08-31 20:19 (3545 d 11:32 ago) – Posting: # 15369
Views: 11,324

Dear PJS
Tmax is a secondary endpoint and undergoes only descriptive statistics.
Don´t try to answer questions nobody asked. So keep the study protocol as simple as it needs to be and if a authority raises questions regarding tmax you can still make up your mind. Without knowing the study outcome it is useless to discuss whether differences are clinically relevant and/or statistically significant.
Kind regards
Dr_Dan

Kind regards and have a nice day
Dr_Dan

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,672 registered users;
172 visitors (0 registered, 172 guests [including 9 identified bots]).
Forum time: 07:52 CEST (Europe/Vienna)

A statistical analysis, properly conducted, is a delicate dissection of
uncertainties, a surgery of suppositions.    Micheal J. Moroney

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5